Literature DB >> 20500018

NeuroAIDS in Africa.

Kevin Robertson1, Jeff Liner, James Hakim, Jean-Louis Sankalé, Igor Grant, Scott Letendre, David Clifford, Amadou Gallo Diop, Assan Jaye, Georgette Kanmogne, Alfred Njamnshi, T Dianne Langford, Tufa Gemechu Weyessa, Charles Wood, Mwanza Banda, Mina Hosseinipour, Ned Sacktor, Noeline Nakasuja, Paul Bangirana, Robert Paul, John Joska, Joseph Wong, Michael Boivin, Penny Holding, Betsy Kammerer, Annelies Van Rie, Prudence Ive, Avindra Nath, Kathy Lawler, Clement Adebamowo, Walter Royal, Jeymohan Joseph.   

Abstract

In July 2009, the Center for Mental Health Research on AIDS at the National Institute of Mental Health organized and supported the meeting "NeuroAIDS in Africa." This meeting was held in Cape Town, South Africa, and was affiliated with the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Presentations began with an overview of the epidemiology of HIV in sub-Saharan Africa, the molecular epidemiology of HIV, HIV-associated neurocognitive disorders (HANDs), and HAND treatment. These introductory talks were followed by presentations on HAND research and clinical care in Botswana, Cameroon, Ethiopia, The Gambia, Kenya, Malawi, Nigeria, Senegal, South Africa, Uganda, and Zambia. Topics discussed included best practices for assessing neurocognitive disorders, patterns of central nervous system (CNS) involvement in the region, subtype-associated risk for HAND, pediatric HIV assessments and neurodevelopment, HIV-associated CNS opportunistic infections and immune reconstitution syndrome, the evolving changes in treatment implementation, and various opportunities and strategies for NeuroAIDS research and capacity building in the region.

Entities:  

Mesh:

Year:  2010        PMID: 20500018      PMCID: PMC3549534          DOI: 10.3109/13550284.2010.489597

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  22 in total

1.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome.

Authors:  David J Riedel; Carlos A Pardo; Justin McArthur; Avindra Nath
Journal:  Nat Clin Pract Neurol       Date:  2006-10

3.  Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

Authors:  C Tscherning; A Alaeus; R Fredriksson; A Björndal; H Deng; D R Littman; E M Fenyö; J Albert
Journal:  Virology       Date:  1998-02-15       Impact factor: 3.616

4.  Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART.

Authors:  Robert F Miller; Peter G Isaacson; Margaret Hall-Craggs; Sebastian Lucas; Françoise Gray; Francesco Scaravilli; Shu F An
Journal:  Acta Neuropathol       Date:  2004-04-14       Impact factor: 17.088

5.  Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Authors:  Paige L Williams; Miguel Marino; Kathleen Malee; Susan Brogly; Michael D Hughes; Lynne M Mofenson
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

6.  Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

Authors:  David B Clifford; Mesfin T Mitike; Yared Mekonnen; Jiameng Zhang; Guta Zenebe; Zenebe Melaku; Ayele Zewde; Neway Gessesse; Dawit Wolday; Tsehaynesh Messele; Mengesha Teshome; Scott Evans
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

7.  Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.

Authors:  Annelies Van Rie; Aimee Mupuala; Anna Dow
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

8.  Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Authors:  Marie-Louise Newell; Hoosen Coovadia; Marjo Cortina-Borja; Nigel Rollins; Philippe Gaillard; Francois Dabis
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

9.  Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes.

Authors:  Eva Poveda; Carmen de Mendoza; Neil Parkin; Sunny Choe; Pilar García-Gasco; Angélica Corral; Vincent Soriano
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

10.  Monitoring psychomotor development in a resource-limited setting: an evaluation of the Kilifi Developmental Inventory.

Authors:  A Abubakar; P Holding; A van Baar; C R J C Newton; F J R van de Vijver
Journal:  Ann Trop Paediatr       Date:  2008-09
View more
  25 in total

1.  Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors:  K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal:  Clin Infect Dis       Date:  2012-06-01       Impact factor: 9.079

2.  Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China.

Authors:  Tingting Zhao; Bo Wei; Jianxiong Long; Xianyan Tang; Mengxiao Zhou; Chao Dang
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

Review 3.  Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.

Authors:  William Tyor; Cari Fritz-French; Avindra Nath
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

4.  Neuropsychological test performance among healthy persons in northern India: development of normative data.

Authors:  Drenna Waldrop-Valverde; Raymond L Ownby; Deborah L Jones; Sunil Sharma; Ritu Nehra; Adarsh M Kumar; Sudesh Prabhakar; Mahendra Kumar
Journal:  J Neurovirol       Date:  2015-03-18       Impact factor: 2.643

5.  Monocyte activation, HIV, and cognitive performance in East Africa.

Authors:  L Arnoldo Muñoz-Nevárez; Brandon M Imp; Michael A Eller; Francis Kiweewa; Jonah Maswai; Christina Polyak; Omalla Allan Olwenyi; I Elaine Allen; Eric Rono; Benedetta Milanini; Hannah Kibuuka; Julie A Ake; Leigh Anne Eller; Victor G Valcour
Journal:  J Neurovirol       Date:  2019-08-29       Impact factor: 2.643

6.  Evaluation of practice effect on neuropsychological measures among persons with and without HIV infection in northern India.

Authors:  Raymond L Ownby; Drenna Waldrop-Valverde; Deborah L Jones; Sunil Sharma; Ritu Nehra; Adarsh M Kumar; Sudesh Prabhakar; Amarilis Acevedo; Mahendra Kumar
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

7.  Proceedings from the NIMH symposium on "NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV".

Authors:  Shilpa Buch; Ernest T Chivero; Jackie Hoare; Jibreel Jumare; Noeline Nakasujja; Victor Mudenda; Robert Paul; Georgette D Kanmogne; Ned Sacktor; Charles Wood; Walter Royal; Jeymohan Joseph
Journal:  J Neurovirol       Date:  2016-07-29       Impact factor: 2.643

8.  Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Authors:  Khutso M Mothapo; J Ten Oever; P Koopmans; F F Stelma; S Burm; J Bajramovic; M M Verbeek; M G Olde Rikkert; M G Netea; G Koopman; A J van der Ven
Journal:  J Neurovirol       Date:  2016-11-23       Impact factor: 2.643

9.  Effects of Tat proteins and Tat mutants of different human immunodeficiency virus type 1 clades on glial JC virus early and late gene transcription.

Authors:  Clayton A Wright; Jonas A Nance; Edward M Johnson
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

10.  International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.

Authors:  K Robertson; H Jiang; S R Evans; C M Marra; B Berzins; J Hakim; N Sacktor; M Tulius Silva; T B Campbell; A Nair; J Schouten; J Kumwenda; K Supparatpinyo; S Tripathy; N Kumarasamy; A la Rosa; S Montano; A Mwafongo; C Firnhaber; I Sanne; L Naini; F Amod; A Walawander
Journal:  J Neurovirol       Date:  2016-01-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.